mitoxantrone has been researched along with Hemorrhage in 5 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Hemorrhage: Bleeding or escape of blood from a vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy of intraarterial chemoperfusion (CP) with mitoxantrone in patients with bleeding bladder cancer; comparison with the results of intraarterial embolization therapy (ET)." | 9.09 | [Locoregional chemoperfusion with mitoxantrone for palliative therapy in bleeding bladder cancer compared with embolization]. ( Dölitzsch, C; Layer, G; Schild, HH; Strunk, H; Textor, HJ; Wilhelm, K, 2000) |
| "To assess the efficacy of intraarterial chemoperfusion (CP) with mitoxantrone in patients with bleeding bladder cancer; comparison with the results of intraarterial embolization therapy (ET)." | 5.09 | [Locoregional chemoperfusion with mitoxantrone for palliative therapy in bleeding bladder cancer compared with embolization]. ( Dölitzsch, C; Layer, G; Schild, HH; Strunk, H; Textor, HJ; Wilhelm, K, 2000) |
| "To evaluate our experience in the treatment of disseminated intravascular coagulation (DIC) associated to AML-M3 with substitution therapy with or without heparin." | 1.29 | [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases]. ( Batlle, J; López Fernández, MF; Rodríguez Gómez, M, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodríguez Gómez, M | 1 |
| López Fernández, MF | 1 |
| Batlle, J | 1 |
| Navarro, JT | 1 |
| Hernández, JA | 1 |
| Ribera, JM | 1 |
| Sancho, JM | 1 |
| Oriol, A | 1 |
| Pujol, M | 1 |
| Millá, F | 1 |
| Feliu, E | 1 |
| Textor, HJ | 1 |
| Wilhelm, K | 1 |
| Strunk, H | 1 |
| Layer, G | 1 |
| Dölitzsch, C | 1 |
| Schild, HH | 1 |
| Salvucci, M | 1 |
| Zanchini, R | 1 |
| Molinari, A | 1 |
| Zuffa, E | 1 |
| Poletti, V | 1 |
| Poletti, G | 1 |
| Zaccaria, A | 1 |
| Johnston, LJ | 1 |
| Stockerl-Goldstein, KE | 1 |
| Hu, WW | 1 |
| Negrin, RS | 1 |
| Hoppe, RT | 1 |
| Blume, KG | 1 |
| Horning, SJ | 1 |
1 trial available for mitoxantrone and Hemorrhage
| Article | Year |
|---|---|
[Locoregional chemoperfusion with mitoxantrone for palliative therapy in bleeding bladder cancer compared with embolization].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Embolization, Therapeutic; Hemorrhage; Humans | 2000 |
4 other studies available for mitoxantrone and Hemorrhage
| Article | Year |
|---|---|
[Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Blood Coa | 1993 |
Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.
Topics: Acute Disease; Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; C | 1998 |
Lung toxicity following fludarabine, cytosine arabinoside and mitoxantrone (flan) treatment for acute leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Hemorrhage; Humans; I | 2000 |
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bo | 2000 |